Compare AEIS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | BIO |
|---|---|---|
| Founded | 1981 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.7B |
| IPO Year | 1995 | N/A |
| Metric | AEIS | BIO |
|---|---|---|
| Price | $220.78 | $323.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $210.22 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 336.3K | 166.1K |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 236.95 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | $1,724,842,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $22.40 | $1.62 |
| Revenue Next Year | $12.62 | $2.26 |
| P/E Ratio | $60.22 | ★ N/A |
| Revenue Growth | ★ 17.19 | N/A |
| 52 Week Low | $75.01 | $211.43 |
| 52 Week High | $232.05 | $373.69 |
| Indicator | AEIS | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 61.72 |
| Support Level | $208.99 | $300.26 |
| Resistance Level | $232.00 | $328.25 |
| Average True Range (ATR) | 6.79 | 7.10 |
| MACD | 0.53 | 2.61 |
| Stochastic Oscillator | 62.50 | 82.49 |
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.